STARTUP PROFILE

Synergia Medical

COUNTRY
Belgium
FOUNDED
2015
CATEGORY
Neuromodulation
Developing optoelectronic, MRI‑compatible vagus nerve stimulator (NAO.VNS) to safely treat drug‑resistant epilepsy via long‑life, fast‑charge implant.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
VNS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Epilepsy
TARGET USER
Patients
REGULATORY STAGE
Investigational
Synergia Medical is differentiated by its optoelectronic, MRI-compatible VNS system with long-life and fast-charge implant architecture, addressing a clinically familiar but still innovation-friendly market in epilepsy. It sits within the implantable neuromodulation tier rather than next-generation non-invasive entrants.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Synergia Medical
No items found.